TY - JOUR
T1 - Point prevalence survey of antimicrobial use during the COVID-19 pandemic among different hospitals in Pakistan
T2 - findings and implications
AU - Saleem, Zikria
AU - Haseeb, Abdul
AU - Godman, Brian
AU - Batool, Narjis
AU - Altaf, Ummara
AU - Ahsan, Umar
AU - Khan, Faiz Ullah
AU - Mustafa, Zia Ul
AU - Nadeem, Muhammad Umer
AU - Farrukh, Muhammad Junaid
AU - Mugheera, Muhammad
AU - Rehman, Inaam Ur
AU - Khan, Asma Fareed
AU - Saeed, Hamid
AU - Hossain, Mohammad Akbar
AU - Raafat, Mohamed
AU - Radwan, Rozan Mohammad
AU - Iqbal, Muhammad Shahid
N1 - Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.
PY - 2023/1
Y1 - 2023/1
N2 - The COVID-19 pandemic has significantly influenced antimicrobial use in hospitals, raising concerns regarding increased antimicrobial resistance (AMR) through their overuse. The objective of this study was to assess patterns of antimicrobial prescribing during the current COVID-19 pandemic among hospitals in Pakistan, including the prevalence of COVID-19. A point prevalence survey (PPS) was performed among 11 different hospitals from November 2020 to January 2021. The study included all hospitalized patients receiving an antibiotic on the day of the PPS. The Global-PPS web-based application was used for data entry and analysis. Out of 1024 hospitalized patients, 662 (64.64%) received antimicrobials. The top three most common indications for antimicrobial use were pneumonia (13.3%), central nervous system infections (10.4%) and gastrointestinal indications (10.4%). Ceftriaxone (26.6%), metronidazole (9.7%) and vancomycin (7.9%) were the top three most commonly prescribed antimicrobials among surveyed patients, with the majority of antibiotics administered empirically (97.9%). Most antimicrobials for surgical prophylaxis were given for more than one day, which is a concern. Overall, a high percentage of antimicrobial use, including broad-spectrums, was seen among the different hospitals in Pakistan during the current COVID-19 pandemic. Multifaceted interventions are needed to enhance rational antimicrobial prescribing including limiting their prescribing post-operatively for surgical prophylaxis.
AB - The COVID-19 pandemic has significantly influenced antimicrobial use in hospitals, raising concerns regarding increased antimicrobial resistance (AMR) through their overuse. The objective of this study was to assess patterns of antimicrobial prescribing during the current COVID-19 pandemic among hospitals in Pakistan, including the prevalence of COVID-19. A point prevalence survey (PPS) was performed among 11 different hospitals from November 2020 to January 2021. The study included all hospitalized patients receiving an antibiotic on the day of the PPS. The Global-PPS web-based application was used for data entry and analysis. Out of 1024 hospitalized patients, 662 (64.64%) received antimicrobials. The top three most common indications for antimicrobial use were pneumonia (13.3%), central nervous system infections (10.4%) and gastrointestinal indications (10.4%). Ceftriaxone (26.6%), metronidazole (9.7%) and vancomycin (7.9%) were the top three most commonly prescribed antimicrobials among surveyed patients, with the majority of antibiotics administered empirically (97.9%). Most antimicrobials for surgical prophylaxis were given for more than one day, which is a concern. Overall, a high percentage of antimicrobial use, including broad-spectrums, was seen among the different hospitals in Pakistan during the current COVID-19 pandemic. Multifaceted interventions are needed to enhance rational antimicrobial prescribing including limiting their prescribing post-operatively for surgical prophylaxis.
KW - antimicrobial resistance
KW - antimicrobial stewardship programs
KW - antimicrobial utilization
KW - COVID-19
KW - irrational use of antibiotics
KW - Pakistan
KW - point prevalence survey
UR - http://www.scopus.com/inward/record.url?scp=85146661146&partnerID=8YFLogxK
U2 - 10.3390/antibiotics12010070
DO - 10.3390/antibiotics12010070
M3 - Article
C2 - 36671271
AN - SCOPUS:85146661146
SN - 2079-6382
VL - 12
SP - 1
EP - 15
JO - Antibiotics
JF - Antibiotics
IS - 1
M1 - 70
ER -